| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Castle Jeremy | Chief Operating Officer | C/O THE ONCOLOGY INSTITUTE, INC., 18000 STUDEBAKER RD. SUITE 800, CERRITOS | /s/ Mark Hueppelheuser, Attorney-in-fact for Jeremy Castle | 22 May 2025 | 0001992507 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | TOI | Common stock | Disposed to Issuer | $15,076 | -5,636 | -2.2% | $2.68 | 247,031 | 21 May 2025 | Direct | F1, F2 |
| Id | Content |
|---|---|
| F1 | The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) pursuant to a sell-to-cover provision included in the RSU Agreement. |
| F2 | Price is the selling price of all sales by the Reporting Person on May 21, 2025. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at the certain price. |